Search

Your search keyword '"Winckler, Wendy"' showing total 318 results

Search Constraints

Start Over You searched for: Author "Winckler, Wendy" Remove constraint Author: "Winckler, Wendy"
318 results on '"Winckler, Wendy"'

Search Results

1. Supplementary Table S3 from Sensitive MRD Detection from Lymphatic Fluid after Surgery in HPV-Associated Oropharyngeal Cancer

2. Data from Sensitive MRD Detection from Lymphatic Fluid after Surgery in HPV-Associated Oropharyngeal Cancer

3. Supplementary Figure S5 from Sensitive MRD Detection from Lymphatic Fluid after Surgery in HPV-Associated Oropharyngeal Cancer

4. Supplementary Methods S1 from Sensitive MRD Detection from Lymphatic Fluid after Surgery in HPV-Associated Oropharyngeal Cancer

5. High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines

6. Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer

7. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico

8. Sensitive MRD Detection from Lymphatic Fluid after Surgery in HPV-Associated Oropharyngeal Cancer

9. Abstract PR09: Detection of minimal residual disease in post-surgical drain fluid can predict locoregional recurrence in HPV-negative head and neck cancer patients

10. Integrated genomic characterization of endometrial carcinoma

11. Comprehensive genomic characterization of squamous cell lung cancers

13. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

14. Comprehensive genomic characterization defines human glioblastoma genes and core pathways

15. Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features

16. Data from Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

17. Interview with Dr. Meyerson from Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

18. Supplementary Figure Legends 1-7 from Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

19. Supplementary Figures 1-7 from Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

20. Supplementary Table 1 from Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

21. Data from Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma

22. Supplementary File 3 from Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer

23. Supplementary File 2 from Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer

24. Supplementary File 1 from Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer

25. Supplementary File 5 from Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer

26. Supplementary File 4 from Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer

27. Supplementary Information from Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma

28. Supplementary File 6 from Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer

29. Materials and Methods, Legends, Tables and Figures from Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer

30. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features

31. Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling

32. Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

33. Novel and accurate measurement of differential protease activity in diagnosed HCC patients compared to non-HCC cirrhotic patients

35. Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2

36. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

37. Drug-Sensitive FGFR2 Mutations in Endometrial Carcinoma

38. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

39. Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors

40. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma

41. Predicting drug susceptibility of non--small cell lung cancers based on genetic lesions

42. Somatic mutations affect key pathways in lung adenocarcinoma

43. Mutational heterogeneity in cancer and the search for new cancer-associated genes

44. Comprehensive molecular portraits of human breast tumours

45. Comprehensive molecular characterization of human colon and rectal cancer

47. Melanoma genome sequencing reveals frequent PREX2 mutations

48. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

49. Initial genome sequencing and analysis of multiple myeloma

50. The genomic complexity of primary human prostate cancer

Catalog

Books, media, physical & digital resources